Research output per year
Research output per year
Personal profile
Biography
Dr. Gautam Behl
Technology Leader, Formulation / Pre-formulation
Dr. Gautam Behl received his Ph.D. from University of Delhi, India and carried out his postdoctoral work at PMBRC WIT and College of Pharmacy and Pharmaceutical Science, Florida A&M University, Florida, USA.
His research has made significant contributions in four areas: (1) Development of lipid and polymer based nanocarriers for the treatment of ocular inflammation (2) Development of microemulsion and liposomal formulations for the treatment of Keratoconjunctivitis sicca. (3) Development of polymeric micelles and nanogels based carriers for treatment of cancer and development of theranostics (4) Treatment of skin cancer through development of novel ultra-flexible lipid based carriers.
Currently Dr. Behl is serving as Technology Leader on Enterprise Ireland funded Technology Gateway Program at PMBRC WIT, where he is working with pharmaceutical industry to develop creative solutions for specific problems encountered, e.g. materials characterization, impurity identification and characterization, compound stability, formulation development, method development and validation. He is also a member of International Association of Advanced Materials, Sweden and American Association of Pharmaceutical Scientists.
Phone: +353 (0) 51834046 Email: gbehl@wit.ie
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Gautam Behl is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
An evaluation of hyaluronic acid and poly(L-lysine) polyelectrolyte complexes for intraocular nicotinamide adenine dinucleotide (NAD+) delivery.
Casey-Power, S., Ryan, R., Behl, G., Mc Loughlin, P., Fitzhenry, L., Byrne, M. E. & Vardar, C., 25 Apr 2023.Research output: Contribution to conference › Poster › peer-review
-
Hyaluronic Acid: Its Versatile Use in Ocular Drug Delivery with a Specific Focus on Hyaluronic Acid-Based Polyelectrolyte Complexes
Casey-Power, S., Ryan, R., Behl, G., McLoughlin, P., Byrne, M. E. & Fitzhenry, L., 15 Jul 2022, In: Pharmaceutics. 14, 7, 41 p., 1479.Research output: Contribution to journal › Review article › peer-review
Open Access6 Citations (Scopus) -
Chitosan-coated plga nanoparticles encapsulating triamcinolone acetonide as a potential candidate for sustained ocular drug delivery
Dandamudi, M., McLoughlin, P., Behl, G., Rani, S., Coffey, L., Chauhan, A., Kent, D. & Fitzhenry, L., Oct 2021, In: Pharmaceutics. 13, 10, 1590.Research output: Contribution to journal › Article › peer-review
Open Access32 Citations (Scopus) -
Dexamethasone-loaded nanostructured lipid carriers for the treatment of dry eye disease
Kumari, S., Dandamudi, M., Rani, S., Behaeghel, E., Behl, G., Kent, D., O’Reilly, N. J., O'Donovan, O., Mc Loughlin, P. & Fitzhenry, L., Jun 2021, In: Pharmaceutics. 13, 6, 905.Research output: Contribution to journal › Article › peer-review
Open Access23 Citations (Scopus) -
The Optimisation of Novel, Hyaluronic Acid and Poly(L-lysine) Polyelectrolyte Complex Formulations for the Intraocular Delivery of NAD+
Casey-Power, S., Fitzhenry, L., Ryan, R., Behl, G., Mc Loughlin, P. & Byrne, M. E., 2021.Research output: Contribution to conference › Poster › peer-review